MarketCap
Bicycle Therapeutics plc BCYC
€ 3.31
1.36%
Facebook
X
Telegram
Land |
 Großbritannien |
IPO-Jahr |
2019 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
69.3 M |
Marktkapitalisierung |
$ 258 M |
EBITDA (LTM) |
$ -154 M |
P/E (LTM) |
-1.881773 |
P/S (LTM) |
3.168386 |
EPS (LTM) |
-2.03 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Merck & Co.
MRK
|
$ 150.29 | 3.88 % | $ 376 B | NYSE,SPB |  USA |
 |
Moderna
MRNA
|
$ 258.45 | 13.14 % | $ 101 B | Nasdaq Global Select Market,SPB | USA |
 |
CorMedix
CRMD
|
$ 5.66 | 1.62 % | $ 408 K | Nasdaq Global Market | USA |
 |
CRISPR Therapeutics AG
CRSP
|
$ 51.69 | 3.4 % | $ 4.65 B | Nasdaq Global Market,SPB |  Schweiz |
 |
Nektar Therapeutics
NKTR
|
$ 38.45 | 1.83 % | $ 649 M | Nasdaq Global Select Market,SPB | USA |
 |
Champions Oncology
CSBR
|
$ 4.84 | 0.21 % | $ 66.9 M | Nasdaq Capital Market | USA |
 |
Checkpoint Therapeutics
CKPT
|
- | - | $ 169 M | Nasdaq Capital Market | USA |
 |
Novartis AG
NVS
|
$ 164.87 | 3.52 % | $ 320 B | NYSE | Schweiz |
 |
Curis
CRIS
|
$ 1.11 | 54.78 % | $ 14.6 M | Nasdaq Global Market | USA |
 |
Ocugen
OCGN
|
$ 0.87 | 17.34 % | $ 272 M | Nasdaq Capital Market | USA |
 |
Oncolytics Biotech
ONCY
|
$ 0.42 | 8.87 % | $ 40.3 M | Nasdaq Global Select Market |  Canada |
 |
ORIC Pharmaceuticals
ORIC
|
$ 9.34 | -2.61 % | $ 820 M | Nasdaq Global Select Market | USA |
 |
Sage Therapeutics
SAGE
|
- | - | $ 527 M | Nasdaq Global Select Market,SPB | USA |
 |
Taro Pharmaceutical Industries Ltd.
TARO
|
- | - | $ 1.62 B | NYSE |  Israel |
 |
Pfizer
PFE
|
$ 30.74 | 2.47 % | $ 175 B | NYSE,SPB | USA |
|
Phathom Pharmaceuticals
PHAT
|
$ 5.68 | -1.13 % | $ 414 M | Nasdaq Global Select Market,SPB | USA |
 |
Cabaletta Bio
CABA
|
$ 1.42 | 0.35 % | $ 143 M | Nasdaq Global Select Market | USA |
 |
Pliant Therapeutics
PLRX
|
$ 0.85 | -1.71 % | $ 52.2 M | Nasdaq Global Select Market | USA |
 |
Forma Therapeutics Holdings
FMTX
|
- | - | $ 958 M | Nasdaq Global Market | USA |
 |
Blueprint Medicines Corporation
BPMC
|
- | - | $ 8.14 B | Nasdaq Global Select Market,SPB | USA |
 |
Prothena Corporation plc
PRTA
|
$ 8.39 | 2.13 % | $ 452 M | Nasdaq Global Select Market,SPB | USA |
 |
Horizon Therapeutics Public Limited Company
HZNP
|
- | - | $ 26.6 B | Nasdaq Global Select Market |  Irlanda |
 |
Protagonist Therapeutics
PTGX
|
$ 143.39 | 2.04 % | $ 9.12 B | Nasdaq Global Select Market | USA |
 |
Codexis
CDXS
|
$ 1.08 | -0.46 % | $ 94.1 M | Nasdaq Global Select Market | USA |
 |
Paratek Pharmaceuticals
PRTK
|
- | - | $ 121 M | Nasdaq Global Market | USA |
 |
Rocket Pharmaceuticals
RCKT
|
$ 2.61 | 3.78 % | $ 290 M | Nasdaq Global Select Market | USA |
 |
Arcus Biosciences
RCUS
|
$ 19.17 | 1.37 % | $ 2.06 B | NYSE,SPB | USA |
 |
Dr. Reddy's Laboratories Limited
RDY
|
$ 14.76 | 3.18 % | $ 12.3 B | NYSE |  India |
 |
Replimune Group
REPL
|
$ 20.68 | 0.12 % | $ 1.92 B | Nasdaq Global Select Market | USA |
 |
ASLAN Pharmaceuticals Limited
ASLN
|
- | -14.27 % | $ 1.7 M | Nasdaq Global Market |  Singapore |
 |
Avidity Biosciences
RNA
|
$ 8.67 | -0.57 % | $ 1.19 B | Nasdaq Global Select Market | USA |
 |
Adverum Biotechnologies
ADVM
|
- | - | $ 86.2 M | Nasdaq Global Market | USA |
 |
Royalty Pharma plc
RPRX
|
$ 67.56 | 1.75 % | $ 29 B | Nasdaq Global Select Market | USA |
 |
Unity Biotechnology
UBX
|
- | -33.41 % | $ 3.37 M | Nasdaq Global Select Market | USA |
 |
Revolution Medicines
RVMD
|
$ 199.48 | 2.7 % | $ 37.9 B | Nasdaq Global Select Market | USA |
 |
iTeos Therapeutics
ITOS
|
- | - | $ 411 M | Nasdaq Global Market | USA |
 |
DBV Technologies S.A.
DBVT
|
$ 9.95 | -1.58 % | $ 1.39 B | Nasdaq Global Select Market |  France |
 |
Rhythm Pharmaceuticals
RYTM
|
$ 105.17 | 21.67 % | $ 6.83 B | Nasdaq Global Market,SPB | USA |
 |
Sana Biotechnology
SANA
|
$ 2.56 | 4.92 % | $ 648 M | Nasdaq Global Select Market | USA |
 |
Achieve Life Sciences
ACHV
|
$ 6.98 | 3.7 % | $ 304 M | Nasdaq Capital Market | USA |
 |
Seelos Therapeutics
SEEL
|
- | -47.76 % | $ 6.27 M | Nasdaq Capital Market | USA |
 |
Advaxis
ADXS
|
- | -9.65 % | $ 45.9 M | Nasdaq Capital Market | USA |
 |
Sol-Gel Technologies Ltd.
SLGL
|
$ 66.7 | 4.53 % | $ 186 M | Nasdaq Global Select Market | Israel |
 |
SELLAS Life Sciences Group
SLS
|
$ 9.15 | 3.1 % | $ 998 M | Nasdaq Capital Market | USA |
 |
Galmed Pharmaceuticals Ltd.
GLMD
|
$ 4.63 | 21.05 % | $ 20 M | Nasdaq Capital Market | Israel |
 |
Syndax Pharmaceuticals
SNDX
|
$ 10.48 | -26.94 % | $ 908 M | Nasdaq Global Select Market | USA |
 |
Kiromic BioPharma
KRBP
|
- | 6.61 % | $ 3.08 M | Nasdaq Global Select Market | USA |
 |
Sanofi
SNY
|
$ 47.45 | 4.67 % | $ 57.9 B | Nasdaq Global Select Market | France |
 |
CNS Pharmaceuticals
CNSP
|
$ 4.21 | -7.47 % | $ 1.87 M | Nasdaq Capital Market | USA |
 |
Spero Therapeutics
SPRO
|
$ 1.07 | 2.88 % | $ 59.9 M | Nasdaq Global Select Market | USA |